General
Emergency authorisation sought for coronavirus vaccines by Pfizer and Oxford-AstraZeneca in India
Emergency authorisation has been sought for the use of Pfizer and Oxford-AstraZeneca’s coronavirus vaccines in India, following the lead of the UK and Russia.
Key points:
- India has reported the second-highest number of coronavirus cases in the world
- The chief executive of one of the world’s largest vaccine producers said approval would “save countless lives”
- Experts say distribution of Pfizer’s vaccine may be difficult in India because it needs to be kept below -70 degrees Celsius
The Serum Institute of India, the world’s largest vaccine producer by volume, sought emergency authorisation in the country for Oxford-AstraZeneca’s COVID-19 vaccine.
The move came close on the heels of Pfizer applying for a similar authorisation of its coronavirus…
-
Noosa News23 hours agoSupernova? High-speed stunt for mystery movie in CBD
-
Noosa News22 hours agoQueensland road rules state drivers must give way to pedestrians, cyclists and e-scooter riders entering or on slip lanes
-
General21 hours agoBody found in reserve in Sydney’s west potentially a middle-aged woman, police say
-
Noosa News19 hours agoJust as Cannes Did, Sydney Film Festival Has Awarded Its Major 2025 Prize to Jafar Panahi’s ‘It Was Just an Accident’